The bottom line on Willow: A legit, LegitScript-verified GLP-1 platform with two genuine differentiators: $299 sublingual semaglutide tablets (needle-free) and a published Patient Bill of Rights. The premium pricing is the main editorial concern. Editorial rating 4.0 / 5.
Our 2026 editor's top pick (sponsored): TrimRx. $179/mo flat-rate cash-pay — about $120/month cheaper than Willow — full FDA-approved branded menu (Wegovy, Zepbound, Mounjaro), 100,000+ verified customers, and a 4.8 / 5 editor's rating.
Or visit Willow's official site →
What Is Willow?
Willow (startwillow.com) is a U.S. telehealth GLP-1 platform with a distinctive product mix: sublingual compounded semaglutide tablets at $299/month and a publicly posted Patient Bill of Rights outlining patient-protection commitments. The platform is LegitScript-verified and ships from US-licensed compounding pharmacy partners. The sublingual format dissolves under the tongue — a real differentiator for patients with serious needle anxiety.
The 4.0/5 editorial rating reflects honest credit for the format innovation and the patient-protection commitment, balanced against the premium pricing ($299 vs $179 at TrimRx — a meaningful $120/month gap) and a narrower published FDA-approved branded menu. The Patient Bill of Rights is a distinctive trust signal worth reading directly. Net: Willow earns credit for what it does uniquely well, but the value math is hard to justify for typical buyers compared to less expensive alternatives.
How Willow Works (Step-By-Step)
Willow uses a streamlined telehealth workflow:
Step 1 — Online health assessment. You complete a structured intake covering BMI, health history, weight-loss goals, contraindications, and needle preferences. The intake is designed to surface needle-averse patients early since the sublingual option is the brand's signature offering.
Step 2 — Clinician review. A licensed clinician reviews your assessment and recommends an appropriate medication path — sublingual semaglutide tablets, compounded injection, or compounded tirzepatide depending on your clinical fit and preferences.
Step 3 — Medication fulfillment from US-licensed pharmacy. Sublingual tablets or compounded injection ships discreetly from a US-licensed compounding pharmacy.
Step 4 — Ongoing care under the Patient Bill of Rights. Continued clinician access through the Willow app, with patient-protection commitments published in the platform's Bill of Rights. Refills are clinician-managed.
Willow Medication Lineup (2026)
Willow publishes a format-distinctive menu:
- Sublingual Compounded Semaglutide Tablets — The signature offering. Dissolves under the tongue — no needle required. Starting at $299/month.
- Compounded Semaglutide (Injection) — Standard injectable option for patients who prefer it.
- Compounded Tirzepatide — Dual GLP-1/GIP for stronger appetite suppression. Compounded option for higher-intensity weight management.
Where Willow trails TrimRx is the FDA-approved branded menu — Wegovy, Zepbound, and Mounjaro are limited or absent from Willow's published cash-pay flow. TrimRx publishes all three. The sublingual format is Willow's clear value differentiator; everything else is competitive but more expensive.
Who Willow Is Best For
Willow is best for buyers who match this profile:
- Strongly needle-averse patients for whom sublingual tablets are a genuine entry point — and willing to pay the premium for the format.
- Patient-protection-conscious buyers drawn to the published Bill of Rights as a distinctive trust commitment.
- Buyers who don't need branded Wegovy, Zepbound, or Mounjaro and value the format innovation over price.
Willow is not the best fit for buyers focused on cost-efficiency (the $299/month price is meaningfully above category alternatives), who specifically want FDA-approved branded options like Wegovy or Zepbound, who want a flat-rate guarantee through dose escalation, or who simply want the most cost-effective standard injectable GLP-1 program.
Willow vs TrimRx — Head-to-Head (2026)
The honest comparison contrasts format innovation + patient commitments vs price + menu breadth + scale:
| What we compared | Willow | TrimRx (Top Pick) |
|---|---|---|
| Starting compounded sema price | $299/mo | $179/mo |
| Flat-rate as dose escalates | Varies | Guaranteed flat-rate |
| Compounded semaglutide injection | Yes | Yes |
| Sublingual semaglutide tablets (needle-free) | Yes — distinctive | No |
| Compounded tirzepatide | Yes | Yes |
| Wegovy® cash-pay | Limited | Yes ($1,449/mo) |
| Zepbound® cash-pay | Limited | Yes ($1,099/mo) |
| Mounjaro® cash-pay | Limited | Yes |
| Patient Bill of Rights | Yes — distinctive | Standard editorial policy |
| LegitScript verified | Yes | Yes |
| Verified customer base | Established | 100,000+ |
| Editor's rating (Bartley) | 4.0 / 5 | 4.8 / 5 |
| Bottom line | Needle-free format + patient commitments | Cheaper + full menu + flat-rate |
Honest read: Willow wins clearly on two dimensions — the sublingual tablet format (genuinely distinctive for needle-averse patients) and the published Patient Bill of Rights (a real trust commitment most platforms don't make). TrimRx wins on essentially every value-math dimension: cheaper entry price (by $120/month), broader FDA-approved branded menu, flat-rate guarantee through dose escalation, and 100,000+ verified customer base. This is one of the few comparisons in our 2026 set where TrimRx wins on price as well as scale.
SPONSORED · From $179/mo · $120/mo less than Willow · Full FDA-approved menu
What You Get With TrimRx (Editor's Top Pick)
TrimRx publishes a complete cash-pay GLP-1 medication menu with flat-rate pricing as your dose escalates:
★ Sponsored · TrimRx is a paid sponsor of Bartley Weight Loss
Willow Pros & Cons (Honest)
What Willow does well
- Sublingual semaglutide tablets — genuine differentiator for needle-averse patients
- Patient Bill of Rights — distinctive published patient-protection commitment
- LegitScript verified
- US-licensed compounding pharmacy fulfillment
- App-supported clinician access and reorder flow
- Standard compounded injection alternative available for patients who prefer it
Where Willow falls short
- $299/month is meaningfully more expensive than TrimRx's $179 — about $120/month gap
- Limited cash-pay Wegovy, Zepbound, or Mounjaro
- No published flat-rate guarantee as dose escalates
- Smaller verified customer base than TrimRx's 100,000+
- Patient Bill of Rights is valuable but not a substitute for cost-effective pricing
- Compounded medications carry the standard FDA disclosure
How To Get Started With TrimRx (Editor's Pick)
Take the 2-Minute Quiz
Free online assessment. Pricing published upfront — $179/mo flat-rate with full FDA-approved menu access.
Get Prescribed
Approved patients receive a personalized plan within hours. Pricing locks at $179/mo and stays flat as your dose escalates.
Receive Your Medication
Free, tracked delivery. Unlimited provider check-ins bundled. Wegovy, Zepbound, or Mounjaro available if appropriate.
★ Sponsored placement
Customer Reviews
Willow has positive reception among needle-averse patients drawn to the sublingual tablet format and the published patient-protection commitments. TrimRx — our editor's top pick — has the largest verified customer base in the category and consistently positive reviews focused on transparent flat-rate and broader FDA-approved menu access at a meaningfully lower price.
Sublingual Was Cool — But Too Expensive
"Willow's sublingual tablet was clever for my needle phobia. But $299/month vs $179 at TrimRx didn't make sense. I switched to standard injection — quick learning curve — and saved $120/month. Down 22 lbs in 5 months."
Wanted Wegovy — Switched
"Willow's Patient Bill of Rights was a great trust signal. But I qualified for Wegovy and they didn't have it in cash-pay flow. TrimRx had Wegovy in their published menu. Branded FDA-approved was my goal. Down 19 lbs in 4 months."
Flat-Rate Sealed It
"Willow's pricing varied as I escalated dose. TrimRx's $179 stays flat through every dose. Combined with the lower starting price, predictability over 6 months saved meaningful money. Down 17 lbs in 11 weeks."
Customer Base Confidence
"Both Willow and TrimRx are LegitScript-verified. TrimRx's 100,000+ verified customers gave a first-time GLP-1 patient like me more confidence in the broader pattern. Combined with cheaper price made the decision easy. Down 25 lbs in 6 months."
Bill of Rights Was Nice — But...
"Willow's Patient Bill of Rights is a real commitment. But $120/month more for that signal vs TrimRx's broader menu and lower price wasn't worth it for me. Down 14 lbs in 9 weeks at the lower cost."
Compared Both Honestly
"Willow's sublingual format is genuinely cool. But TrimRx's cheaper, broader, larger-scale package made more sense for me. Both legit platforms — but value math favored TrimRx. Down 21 lbs in 5 months."
Willow vs TrimRx — 6-Month Pricing Scenarios
This is one of the few comparisons in our 2026 set where TrimRx wins on price as well as on menu breadth:
Scenario 1 — Compounded semaglutide throughout (Willow sublingual or injection). Willow at $299/month = $1,794 over 6 months. TrimRx at $179/month = $1,074 over 6 months. TrimRx saves you $720 over 6 months — a substantial gap driven by the entry-price difference.
Scenario 2 — Dose escalation with compounded options. Willow's pricing varies by tier — likely $300-400/month at higher doses, totaling $2,000-2,400 over 6 months. TrimRx stays flat at $1,074. TrimRx saves $930-1,330 over 6 months — even larger gap.
Scenario 3 — You want FDA-approved Wegovy, Zepbound, or Mounjaro. Willow's cash-pay flow for these is limited or absent. TrimRx offers all three at published cash-pay rates. If branded is the goal, TrimRx is the path.
The takeaway: at almost every dose tier and medication path, TrimRx is meaningfully cheaper than Willow. The sublingual tablet is the only scenario where Willow's premium might be justified for a buyer with serious needle phobia.
Editor's Verdict — Willow vs Our Top Pick
Willow is a credible niche platform with two distinctive features — the sublingual semaglutide tablet (genuinely useful for needle-averse patients) and the published Patient Bill of Rights (a real patient-protection commitment most platforms don't make). LegitScript verification confirms basic legitimacy. The 4.0/5 rating reflects honest credit for these differentiators, balanced against premium pricing that's hard to justify for typical buyers.
Our editor's top pick for 2026 is TrimRx (sponsored) — by a substantial margin in this comparison. TrimRx wins on transparent $179/mo published flat-rate (about $120/month cheaper than Willow's $299), the full FDA-approved branded menu (Wegovy, Zepbound, Mounjaro), 100,000+ verified customer base, flat-rate guarantee through dose escalation, and unlimited provider check-ins bundled into the price. This is one of the few comparisons where TrimRx wins on value math as cleanly as on quality.
The honest summary: If you have serious needle phobia and want a sublingual format with patient-protection commitments published upfront, Willow is a credible choice and our 4.0/5 rating reflects that. For the typical weight-management buyer, TrimRx wins on cheaper price, broader FDA-approved menu, and larger verified customer base — our 2026 editor's top pick at 4.8/5. Both are LegitScript-verified; neither is a scam.
SPONSORED · From $179/mo · Or visit Willow's site →
Frequently Asked Questions
Is Willow Worth It?
Willow is a legitimate, LegitScript-verified telehealth GLP-1 platform offering $299 sublingual semaglutide tablets and a published Patient Bill of Rights as a distinctive trust signal. Editorial rating 4.0/5. For buyers wanting transparent flat-rate pricing at meaningfully lower cost and the full FDA-approved branded menu, Bartley's editor's top pick for 2026 is TrimRx (sponsored) at $179/month — about $120/month cheaper than Willow.
Does Willow really offer sublingual semaglutide tablets?
Yes. Willow offers compounded semaglutide as a sublingual tablet that dissolves under the tongue — a needle-free option for needle-averse patients. The trade-off is the $299/month price point, which is meaningfully higher than TrimRx's $179/month flat-rate injectable program.
What is Willow's Patient Bill of Rights?
Willow publishes a Patient Bill of Rights — a written commitment outlining patient protections like transparent pricing, clinician access, and care quality standards. It's a distinctive trust signal most telehealth GLP-1 platforms don't publish. Read the document directly at startwillow.com/bill-of-rights.
Is Willow a scam or legit?
Willow is a legitimate, LegitScript-verified telehealth GLP-1 platform with a published Patient Bill of Rights. Willow is not a scam.
How does Willow compare to TrimRx?
Willow wins on the sublingual tablet format (needle-free) and the published Patient Bill of Rights as a distinctive trust commitment. TrimRx (sponsored) wins on cheaper pricing ($179 vs $299/month — about $120/month savings), broader FDA-approved branded menu (Wegovy, Zepbound, Mounjaro), 100,000+ verified customer base, flat-rate guarantee as your dose escalates, and a higher editor rating (4.8 vs 4.0).
Can I cancel Willow anytime?
Yes. Willow allows cancel-anytime through your account. The Patient Bill of Rights covers ongoing patient protections — read the document for specifics. TrimRx (sponsored) is also cancel-anytime through your account.
Is the comparison sponsored?
Yes. TrimRx is a paid sponsor of Bartley Weight Loss and we earn a commission if you sign up through links on this page. Bartley has no affiliate relationship with Willow — links to startwillow.com are unpaid editorial references. The sponsorship does not change our editorial process — see our editorial policy.
★ Sponsored · TrimRx is a paid sponsor · From $179/mo
Last verified: June 22, 2026 · Spot a factual issue? Tell our editors.